It's Official: VWR Sold in $6.4 Billion Deal Post author:Sam Post published:May 4, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Ablynx Banks $200M IPO in Nasdaq Debut October 24, 2017 Nabriva Reports Second Quarter 2017 Financial Results And Recent Corporate Highlights August 6, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017